BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 12409719)

  • 1. Monophasic fibrous and poorly differentiated synovial sarcoma: immunohistochemical reassessment of 60 t(X;18)(SYT-SSX)-positive cases.
    Pelmus M; Guillou L; Hostein I; Sierankowski G; Lussan C; Coindre JM
    Am J Surg Pathol; 2002 Nov; 26(11):1434-40. PubMed ID: 12409719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue microarray profiling of primary and xenotransplanted synovial sarcomas demonstrates the immunophenotypic similarities existing between SYT-SSX fusion gene confirmed, biphasic, and monophasic fibrous variants.
    Subramaniam MM; Navarro S; Pellin A; López-Guerrero JA; Carda C; Heredia Alvaro JA; Gozalbo Sabater PL; Llombart-Bosch A
    Virchows Arch; 2006 Oct; 449(4):435-47. PubMed ID: 16957934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma.
    Antonescu CR; Kawai A; Leung DH; Lonardo F; Woodruff JM; Healey JH; Ladanyi M
    Diagn Mol Pathol; 2000 Mar; 9(1):1-8. PubMed ID: 10718206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of the synovial sarcoma translocation t(X;18) (SYT;SSX) in paraffin-embedded tissues using reverse transcriptase-polymerase chain reaction: a reliable and powerful diagnostic tool for pathologists. A molecular analysis of 221 mesenchymal tumors fixed in different fixatives.
    Guillou L; Coindre J; Gallagher G; Terrier P; Gebhard S; de Saint Aubain Somerhausen N; Michels J; Jundt G; Vince DR; Collin F; Trassard M; Le Doussal V; Benhattar J
    Hum Pathol; 2001 Jan; 32(1):105-12. PubMed ID: 11172303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of SYT-SSX fusion transcripts in archival synovial sarcomas by real-time reverse transcriptase-polymerase chain reaction.
    Bijwaard KE; Fetsch JF; Przygodzki R; Taubenberger JK; Lichy JH
    J Mol Diagn; 2002 Feb; 4(1):59-64. PubMed ID: 11826189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
    Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
    Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary intrathoracic synovial sarcoma: a clinicopathologic study of 40 t(X;18)-positive cases from the French Sarcoma Group and the Mesopath Group.
    Bégueret H; Galateau-Salle F; Guillou L; Chetaille B; Brambilla E; Vignaud JM; Terrier P; Groussard O; Coindre JM
    Am J Surg Pathol; 2005 Mar; 29(3):339-46. PubMed ID: 15725802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of SYT-SSX fusion products in soft tissue tumors other than synovial sarcoma.
    van de Rijn M; Barr FG; Collins MH; Xiong QB; Fisher C
    Am J Clin Pathol; 1999 Jul; 112(1):43-9. PubMed ID: 10396284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases.
    Coindre JM; Pelmus M; Hostein I; Lussan C; Bui BN; Guillou L
    Cancer; 2003 Dec; 98(12):2700-7. PubMed ID: 14669292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma.
    Amary MF; Berisha F; Bernardi Fdel C; Herbert A; James M; Reis-Filho JS; Fisher C; Nicholson AG; Tirabosco R; Diss TC; Flanagan AM
    Mod Pathol; 2007 Apr; 20(4):482-96. PubMed ID: 17334349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.
    Kawai A; Woodruff J; Healey JH; Brennan MF; Antonescu CR; Ladanyi M
    N Engl J Med; 1998 Jan; 338(3):153-60. PubMed ID: 9428816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular diagnosis of synovial sarcoma: RT-PCR detection of SYT-SSX1/2 fusion transcripts in paraffin-embedded tissue.
    Tvrdík D; Povýsil C; Svatosová J; Dundr P
    Med Sci Monit; 2005 Mar; 11(3):MT1-7. PubMed ID: 15735574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Roles of immunohistochemistry and detection of SYT-SSX fusion gene in diagnosis of synovial sarcoma].
    Sun Y; Sun BC; Zhao XL; Wang J; Chen J; Li XQ; Feng YM; Fang ZW; Hao XS
    Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):480-4. PubMed ID: 17845763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual primary intracranial dural-based poorly differentiated synovial sarcoma with t(X; 18)(p11; q11).
    Lin YJ; Yang QX; Tian XY; Li B; Li Z
    Neuropathology; 2013 Feb; 33(1):75-82. PubMed ID: 22537253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary synovial sarcoma of the prostate: report of 2 cases and literature review.
    Jun L; Ke S; Zhaoming W; Linjie X; Xinru Y
    Int J Surg Pathol; 2008 Jul; 16(3):329-34. PubMed ID: 18387992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary pleuropulmonary and mediastinal synovial sarcoma: a clinicopathologic and molecular study of 26 genetically confirmed cases in the largest institution of southwest China.
    Lan T; Chen H; Xiong B; Zhou T; Peng R; Chen M; Ye F; Yao J; He X; Wang Y; Zhang H
    Diagn Pathol; 2016 Jul; 11(1):62. PubMed ID: 27401493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poorly differentiated synovial sarcoma: an analysis of clinical, pathologic, and molecular genetic features.
    van de Rijn M; Barr FG; Xiong QB; Hedges M; Shipley J; Fisher C
    Am J Surg Pathol; 1999 Jan; 23(1):106-12. PubMed ID: 9888710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of cytokeratin subsets for distinguishing poorly differentiated synovial sarcoma from peripheral primitive neuroectodermal tumour.
    Machen SK; Fisher C; Gautam RS; Tubbs RR; Goldblum JR
    Histopathology; 1998 Dec; 33(6):501-7. PubMed ID: 9870143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
    Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
    Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.
    Jagdis A; Rubin BP; Tubbs RR; Pacheco M; Nielsen TO
    Am J Surg Pathol; 2009 Dec; 33(12):1743-51. PubMed ID: 19809272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.